Suppliers / Novartis

Novartis

Switzerland 3 duplicate records merged Updated 9 July 2026

The public registers hold a second record for Novartis. The fuller profile, with 10 active US DMFs and 3 valid CEPs, is at Novartis. Figures on this page cover only this record.

Novartis is a finished-dose manufacturer based in Switzerland. It appears in 482 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with INHRR (VE), EDA (EG) and SFDA (Saudi Arabia).

0
active US DMFs
0
valid CEPs
1
registered plants
482
filings across 7 regulators

Registered plants

Site FDA FEI
CASABLANCA, Morocco Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
INHRR (VE) 236 None
EDA (EG) 156 None
SFDA (Saudi Arabia) 54 None
DAV (Vietnam) 17 None
DMP (NO) 17 None
ARCSA (EC) 1 None

Questions about Novartis

Does Novartis hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Novartis. It does have 482 filings with 7 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Novartis manufacture?
1 registered site is on record, in Morocco (Casablanca). Every site is listed on this page with the register it came from.
Where does Novartis file?
Filings are on record with INHRR (VE), EDA (EG), SFDA (Saudi Arabia), DAV (Vietnam) and 3 other regulators, 482 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Novartis comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability